Virology - Molecular Tools and Viral Genomics

Molecular Biology Techniques in Virology Introduction Working with viruses requires specialized laboratory techniques to isolate, identify, and manipulate viral components. This section covers the fundamental methods scientists use to purify viruses, separate and visualize their components, sequence their genomes, and create genetically modified viral strains. These techniques form the backbone of modern virology research and clinical diagnostics. Purification of Viruses and Components Before analyzing viral properties or using viruses for research, scientists must remove contaminating particles and cellular material. This requires a systematic approach using centrifugation methods. Differential Centrifugation Differential centrifugation exploits differences in particle size and density to progressively purify viruses. The process works in stages: Low-speed centrifugation (typically 1,000–10,000 × g) first removes large debris—unbroken cells, cell nuclei, and mitochondria settle as a pellet while smaller viral particles remain in the supernatant (the liquid above the pellet). High-speed ultracentrifugation (typically 100,000 × g or higher) then pellets the viral particles themselves, which sediment more slowly than larger structures but much faster than dissolved proteins. The key principle: centrifugal force pushes heavier or denser particles outward faster, causing them to separate based on their sedimentation rate. Buoyant Density Centrifugation While differential centrifugation separates by size, buoyant density centrifugation separates by density alone. This technique uses a density gradient—a solution that gradually increases in density from top to bottom. The most common gradient uses cesium chloride (CsCl), which creates a smooth density range. When a virus sample is loaded onto this gradient and centrifuged, each virus type moves to the layer where its density matches the surrounding solution density—a position where it no longer floats up or sinks down. This equilibrium separation can isolate viruses from proteins (which have different buoyant densities) and even separate nucleic acids from protein coats. Electrophoretic Separation After purification, researchers often need to separate viral proteins or nucleic acids to examine individual components. Gel electrophoresis accomplishes this by using electrical current to push charged molecules through a porous matrix. How Gel Electrophoresis Works Proteins and nucleic acids are charged molecules. In an electric field, they migrate toward the electrode of opposite charge. The gel matrix (made of either agarose or polyacrylamide) acts like a molecular sieve—smaller molecules move faster through the pores, while larger molecules move more slowly. The result is separation by molecular size: molecules of the same charge but different sizes end up at different positions along the gel, creating distinct bands. Visualization with Stains The separated molecules are invisible unless stained: Coomassie blue binds to proteins and turns them bright blue, making protein bands visible Ethidium bromide intercalates into DNA and RNA, fluorescing under ultraviolet (UV) light, making nucleic acid bands visible This combination of separation and staining allows researchers to verify the purity and size of viral proteins or genomes. Genome Sequencing Modern virology depends critically on determining viral nucleotide sequences—the order of bases in viral DNA or RNA. Two main approaches are used today. Sanger Sequencing Sanger sequencing is the classical method. It works by synthesizing new DNA strands that are complementary to the target sequence, but incorporating chain-terminating nucleotides (called dideoxynucleotides, or ddNTPs) at random positions. This produces a collection of DNA fragments of different lengths, each terminating at a different position in the sequence. By separating these fragments by size, the sequence can be read like a ladder. Sanger sequencing is highly accurate and still used for validating sequences, though it is slower and more labor-intensive than newer methods. Next-Generation Sequencing (NGS) Next-generation sequencing technologies dramatically increased sequencing speed and throughput. NGS machines simultaneously sequence millions of small DNA fragments (called reads), generating enormous amounts of sequence data quickly and at lower cost. For viral research, these millions of reads are computationally assembled into complete viral genome sequences. NGS is the standard approach for discovering new viruses, surveying viral populations, and sequencing clinical samples. Over two million unique viral sequences have been deposited in public databases like GenBank, providing a searchable reference for comparing newly discovered viruses against known sequences. Phylogenetic Analysis Once viral sequences are obtained, comparing them reveals evolutionary relationships. Phylogenetic analysis constructs evolutionary trees that show how viruses relate to one another. Building Phylogenetic Trees Specialized software (such as PHYLIP) compares viral genome sequences and calculates evolutionary distances—roughly, the percentage of nucleotides that differ between two sequences. Viruses with very similar sequences are placed close together on the tree; distantly related viruses are farther apart. The tree branches represent inferred common ancestors. Why This Matters Phylogenetic trees serve several critical functions: Tracing origins: identifying where a new viral outbreak originated Understanding spread: showing how a virus has evolved as it spread through a population Detecting recombination: identifying regions where two viruses have exchanged genetic material Predicting antigenicity: similar sequences often indicate similar immune responses Cloning of Viral Genes Producing viral proteins for research or vaccines without culturing the actual virus is possible through cloning. This process inserts viral genes into cloning vectors—usually plasmids, small circular DNA molecules that can replicate independently in bacterial cells. The Process Viral nucleotide sequences (usually derived from cDNA reverse-transcribed from viral RNA) are inserted into a plasmid The recombinant plasmid is introduced into bacterial cells Bacteria reproduce rapidly, copying the plasmid and its viral gene insert millions of times The cloned viral genes can be expressed (transcribed and translated) in the bacteria to produce viral proteins Advantages This approach has major benefits: Safety: no need to culture infectious virus Scale: bacteria grow rapidly, producing large quantities of viral protein Purity: the desired viral protein can be purified away from other bacterial proteins Reproducibility: the cloned gene sequence is permanent and stable Cloned viral genes are particularly valuable for developing diagnostic tests and vaccine antigens. Phage Virology Bacteriophages (or phages) are viruses that infect bacteria, archaea, and fungi. Despite their small size and simple nature, phages are extraordinarily useful research tools. Applications Phage display: protein sequences are fused to phage coat proteins, allowing researchers to screen millions of variants for desired properties (binding affinity, enzymatic activity, etc.) Model system: phages replicate rapidly and have small genomes, making them ideal for studying fundamental viral biology, genetic recombination, and replication mechanisms Tools: phages are used to transfer DNA between bacteria (a process called transduction) and to study bacterial genetics <extrainfo> Phage virology is a classical field that contributed many foundational insights to molecular biology. The study of phages like T4 and λ (lambda) in the mid-20th century established basic principles of DNA replication, gene regulation, and recombination that apply broadly across biology. </extrainfo> Viral Genetics Viruses generate genetic diversity through multiple mechanisms. Understanding these processes explains how viral populations change and adapt. Reassortment Some viruses have segmented genomes—multiple separate RNA or DNA molecules, each encoding different genes. Influenza virus, for example, has eight separate RNA segments. Reassortment occurs when two different viruses infect the same cell and exchange whole genome segments. A daughter virus might inherit segments from both parent viruses, creating a new combination of genes. This is fundamentally different from gradual evolution—it creates novelty through wholesale segment swapping. When it matters: Reassortment becomes epidemiologically important when, for example, a human-adapted influenza virus and an animal influenza virus co-infect the same host cell, producing a hybrid virus that might be novel to human immune systems. Recombination Recombination is the joining of nucleic acid fragments from different parent viruses during replication. Unlike reassortment, recombination can occur at any point along the genome—not just at segment boundaries. During replication, when two viral genomes are being copied in the same cell, the replication machinery can switch from copying one parent genome to the other, creating a recombinant genome with nucleotide sequences from both parents. This generates genetic variation within segments and is a source of evolutionary change in all viruses. Reverse Genetics and Infectious Clones Reverse genetics reverses the typical direction of investigation: instead of observing a virus and inferring its genes, researchers design specific genes and create viruses that carry them. The Approach The complete viral genome sequence is copied into cDNA (complementary DNA, made from viral RNA) This cDNA is cloned into plasmids—one plasmid per genome segment (for segmented viruses) or one large plasmid for non-segmented viruses The plasmids are introduced into cells, which reconstitute infectious viral particles The reconstituted viruses are infectious clones—their genomes are known sequences that can be manipulated genetically Research Applications Reverse genetics enables researchers to: Examine gene function: delete or mutate specific genes and observe the phenotypic effects Study virulence: identify which genetic changes make a virus more or less dangerous Assess transmissibility: determine genetic requirements for spreading between hosts Develop vaccines: create attenuated (weakened) strains with reduced disease potential The power of this approach is genetic precision: scientists know exactly which nucleotides have been changed and can causally link genetic changes to phenotypic outcomes. Viral Genomics, Bioinformatics, and Metaviromics High-Throughput Sequencing of Viral Genomes Next-generation sequencing generates millions of short reads—typically 50–250 bases each—very rapidly. For viral genome projects, these reads must be assembled into complete sequences. Assembly works by finding overlaps: if read A's end matches read B's beginning, they overlap and can be joined. Specialized software detects all such overlaps and stitches reads together into longer contigs (continuous sequences), ultimately reconstructing complete viral genomes. This approach has made it possible to sequence viral genomes in days or even hours, a dramatic acceleration from the months or years required by Sanger sequencing alone. Metaviromics: Exploring Viral Communities Metaviromics takes a fundamentally different approach to discovering viruses. Instead of culturing viruses or extracting them from known infected hosts, metaviromics: Collects environmental samples (soil, ocean water, sewage, respiratory secretions, gut contents, etc.) Extracts all nucleic acids directly from the sample Sequences the entire pool of genetic material Computationally separates viral sequences from host and bacterial sequences Why This Matters This approach has revealed enormous viral diversity previously unknown: Environmental viruses: thousands of new phages and plant viruses in natural ecosystems Human virome: diverse viral populations in the gut, respiratory tract, and other sites, including viruses not culturable in the lab Rare and emerging viruses: viruses present at low levels or in unexpected hosts Metaviromics has fundamentally expanded our understanding of the virosphere—the total viral diversity on Earth. Most viruses are still unknown; metaviromics discovers them without needing to culture them. Phylogenetic Analysis and Virus Evolution Phylogenetic trees constructed from viral genome sequences reveal not just relationships but also evolutionary patterns. By sequencing many strains and comparing them: Origins are traced: determining geographic regions and likely animal or plant sources Transmission chains are mapped: showing how viruses spread through human populations Recombination is detected: certain regions of a genome may have evolutionary histories that disagree with others, indicating past recombination <extrainfo> Recent examples illustrate this power. Phylogenetic analyses of SARS-CoV-2 sequences early in the pandemic helped establish that the virus originated in bats, identified the likely initial human spillover event in Wuhan, and tracked spread to other continents. Similarly, analysis of Ebola virus sequences has repeatedly identified animal reservoir sources and traced outbreaks to specific transmission events. </extrainfo> Reverse Genetics and Viral Engineering Reverse Genetics for Influenza Virus Influenza virus is a segmented virus—eight separate RNA molecules, each packaged into virions. Reverse genetics for influenza is particularly elegant: All eight viral RNA segments are reverse-transcribed into cDNA and cloned into plasmids Each plasmid is introduced into mammalian cells (not bacteria, because influenza genes need eukaryotic transcription machinery to be properly expressed) Cells co-transfected with all eight plasmids produce authentic influenza viruses This approach enabled the construction of reassortant viruses—viruses combining genes from two different strains—without requiring natural co-infection. Researchers can deliberately combine genes from seasonal virus strains with genes conferring immunological novelty, or study the impact of individual genetic changes by comparing viruses differing at just one or two nucleotides. Vaccine Development Reverse genetics has accelerated flu vaccine development. If a novel influenza strain emerges but grows poorly in standard lab media, researchers can use reverse genetics to transfer its surface protein genes (hemagglutinin and neuraminidase) onto a vaccine strain backbone that grows well, creating a vaccine strain matching the pandemic virus but replicating efficiently for industrial production. Construction of Recombinant Adenovirus Vectors Adenoviruses are large DNA viruses with genomes large enough to accommodate foreign genes. Scientists have engineered adenoviruses as vectors—vehicles for delivering genes into cells. Recombinant adenoviruses typically have: Viral genes necessary for replication and cell entry intact (allowing the vector to infect target cells) Early viral genes deleted (reducing viral protein expression and immune responses) Foreign genes inserted in place of the deleted genes (allowing production of desired proteins in infected cells) Applications Gene therapy: delivering corrective genes to replace defective cellular genes Vaccine delivery: expressing viral antigens or tumor antigens in cells to trigger immune responses Research: introducing experimental genes to study their effects in living tissues The advantage of adenovirus vectors is their size capacity (allowing large inserts), their ability to infect many cell types, and their safety profile in modern designs.